Home / Therapies / GLP-1 Agonist Therapy Center (page 27)

GLP-1 Agonist Therapy Center

GLP-1 Diabetes Drug Treatment: GLP-1 (glucagon-like peptide 1 receptor agonists) are incretin mimetics which have several benefits for diabetes management. They suppress post-prandial glucagon release, delay stomach emptying, and increase insulin sensitivity. Significantly lower rates of hypoglycemia accompany GLP-1 therapy. This class also has the side effect of modest weight reduction and reduction of systolic blood pressure. GLP-1 receptor agonists are counter-indicated for patients with a history of pancreatitis.

GLP-1 Knowledge Survey Part II

Jun 29, 2011 Articles, GLP-1 Agonist Therapy Center 3,918 views

We asked our readers to give us feedback into how much they knew about GLP-1 Analogs and a broad cross-section replied. Take a look at 5 of the questions and how your colleagues answered…. It appears that most of you knew that a large amount of GLP-1 production is lost …

GLP-1 Knowledge Survey Part I

Jun 22, 2011 Articles, GLP-1 Agonist Therapy Center 4,265 views

Thanks to the great number of you who participated. As we put together the original survey our first thoughts were to find out what you wanted to know about GLP-1 analogs and what your impressions of the class of drugs are…. We asked you “what were the most important things …

Page 27 of 27« First...10 20 «23 24 25 2627